The scalable platform can be initially deployed, and later upgraded to include Hospira MedNet™ safety software to meet your evolving patient care needs. The unique, innovative PlumSet ...

But his job took an unexpected turn in 2010, when Hospira, the maker of the drug sodium thiopental, stopped production in the US due to an unspecified issue with obtaining raw materials.

Hospira has proven that biosimilar companies can make mistakes every bit as foolish as companies with originator products, after having arranged a lavish foreign trip for NHS pharmacists.

Hospira isn't the only generics company trying to bring a version of regadenoson to the US market. AmphaStar and Glenmark Pharma also claimed FDA approval for versions of the drug earlier this year.

ICU Medical acquired Hospira Infusion Systems in February 2017 and established itself as a leader in infusion therapy. But in July of that year, ICU Medical announced a voluntary recall due to ...

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software, and ...

Acquisition strengthens Lyell’s clinical pipeline with the addition of IMPT-314, a dual-targeting CD19/CD20 CAR T-cell ...

Investors this weekend shifted their focus to big moves disclosed by Berkshire Hathaway (BRK.A)(BRK.B). The conglomerate led ...

He is a former director of Computer Sciences Corporation (NYSE: CSC), Hospira, Inc. (NYSE: HSP) and the Board of Governors of the National Association of Small Business Investment Companies (NASBIC).

The following real estate transactions were recorded recently at the Johnston County Courthouse: Jeff D. Rogers, substitute trustee, and GSW Inc. to Branch Banking & Trust Co., 22 acres in Meadow ...

Dr. Victoria Medvec is the Adeline Barry Davee Professor of Management and Organizations at the Kellogg School of Management at Northwestern University. In addition, Dr. Medvec is a co-founder and the ...

ISMP would like to thank the 715 practitioners, mostly pharmacy directors and managers, staff pharmacists, clinical pharmacists, and medication safety pharmacists, who responded to our recent ...